Showing 2131-2140 of 2735 results for "".
- Korean Skincare Brand Launches in US with Sensitive-Skin Formulationshttps://modernaesthetics.com/news/korean-skincare-brand-launches-in-us-with-sensitive-skin-formulations/2483054/South Korean skincare brand Hexkin has entered the US market, offering products formulated for sensitive skin using collagen-based and peptide-driven technologies, according to a press release. Rooted in traditional Korean sk
- Virtual Surgical Planning Gains Ground in Maxillofacial Procedureshttps://modernaesthetics.com/news/virtual-surgical-planning-gains-ground-in-maxillofacial-procedures/2482935/Virtual surgical planning (VSP) is becoming a mainstay in oral and maxillofacial surgery, offering improved precision, shorter operative times, and more predictable patient outcomes. Increasingly used for procedures such as genioplasty and orthognathic surgery, VSP combines digital imaging with c
- TOPICAL SKIN Launches Antioxidant Face Oilhttps://modernaesthetics.com/news/topical-skin-launches-antioxidant-face-oil/2476145/Skincare brand TOPICAL SKIN launched Phyto AOX Face Oil N°10, a plant-based facial oil developed to protect the skin from environmental damage such as pollution, UV rays, and blue light. The formula features a proprietary Exposome Defense Technology, describ
- AMI Pharm Advances AYP-101 to Phase 3 Testing for Noninflammatory Fat Reductionhttps://modernaesthetics.com/news/ami-pharm-advances-ayp-101-to-phase-3-testing-for-noninflammatory-fat-reduction/2476093/AMI Pharm has initiated a pivotal Phase 3 clinical trial of AYP-101, an investigational injectable for the treatment of submental fat. The study will evaluate the efficacy and safety of the agent, which is designed to reduce localized fat with fewer inflammatory side effects than current therapie
- SkinCeuticals Introduces A.G.E. Interrupter Ultra Serum to Address Sagging Skinhttps://modernaesthetics.com/news/skinceuticals-introduces-age-interrupter-ultra-serum-to-address-sagging-skin/2476036/SkinCeuticals announced the launch of its A.G.E. Interrupter Ultra Serum, a new addition to its A.G.E. line designed to target skin laxity. Sagging skin, often heightened by factors such as rapid weight loss, has become a growing concern among patients seeking dermatologic care. This serum offers
- Merz Aesthetics Names New US Sales and Marketing Leadershttps://modernaesthetics.com/news/merz-aesthetics-names-new-us-sales-and-marketing-leaders/2475952/Merz Aesthetics has appointed Chris Van Dyk as Vice President of US Sales and DJ Sethares as Vice President of US Marketing, the company announced. Both executives will lead commercial functions across the US to support growth of the company’s aesthetics portfolio. Van Dyk previously serve
- Alma Launches AI-Assisted Skincare System with Nearly 12M Formulation Optionshttps://modernaesthetics.com/news/alma-launches-ai-assisted-skincare-system-with-nearly-12m-formulation-options/2475858/Alma has launched Universkin by Alma, a new AI-assisted medical-grade skincare platform designed to support physicians in offering personalized treatment regimens. The system enables rapid clinical assessment and tailored formulation of topical therapies using an intelligent diagnostic algorithm
- BOTOX Cosmetic Selects Entrepreneurs for 2025 Confidence Projecthttps://modernaesthetics.com/news/botox-cosmetic-selects-entrepreneurs-for-2025-confidence-project/2475812/Allergan Aesthetics, an AbbVie company, announced the 2025 class of participants in The Confidence Project: Empowering Women Entrepreneurs, a national program led by BOTOX Cosmetic (onabotulinumtoxinA). The initiative is designed to address the confidence gap among women in business and
- Global Botulinum Toxins Market Projected to Reach $15.7 Billion by 2030https://modernaesthetics.com/news/global-botulinum-toxins-market-projected-to-reach-157-billion-by-2030/2475785/The global market for botulinum toxin products is expected to grow from $8.9 billion in 2025 to $15.7 billion by 2030, according to new projections from MarketsandMarkets, representing a compound annual growth rate (CAGR) of 11.7%. This sustained growth is attributed to increased global de
- Study: CINDR of Masseter Muscle Optimal Injection Site for Botoxhttps://modernaesthetics.com/news/study-cindr-of-masseter-muscle-optimal-injection-site-for-botox/2475664/Research published in the Annals of Anatomy journal indicates the center of the intramuscular nerve dense region (CINDR) of the masseter muscle as the optimal botulinum neurotoxin A (BoNT-A) injection site. The researchers used 60 rabbits to assess BoNT-A injection efficacy at the CINDR.<